Progression of autosomal-dominant polycystic kidney disease in children

被引:107
|
作者
Fick-Brosnahan, GM
Tran, ZV
Johnson, AM
Strain, JD
Gabow, PA
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Biometr & Radiol, Denver, CO 80262 USA
[3] Childrens Hosp, Denver, CO USA
关键词
kidney volume; end-stage renal disease; renin-angiotensin-aldosterone system; hematuria; hypertension; childhood renal disease progression; cyst enlargement;
D O I
10.1046/j.1523-1755.2001.0590051654.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Although many case reports describe manifestations of autosomal-dominant polycystic kidney disease (ADPKD) in children, no longitudinal studies have examined the natural progression or risk factors for more rapid progression in a large number of children from ADPKD families. Methods. Since 1985, we have studied 312 children from 131 families with a history, a physical examination, blood and urine chemistries, an abdominal ultrasonography, and gene linkage analysis. One hundred fifteen of 185 affected children were studied multiple times for up to 15 years. Renal volumes were determined by ultrasound imaging. Graphs of mean renal volumes according to age were compared between affected and unaffected children, ADPKD children with and without early severe disease, and children with and without high blood pressure. Results. Affected children had faster renal growth than unaffected children. ADPKD children with severe renal enlargement at a young age continued to experience faster renal growth than those with mild enlargement or normal kidney size for their age, and affected children with high blood pressure had faster renal growth than those with lower blood pressure. Glomerular filtration rate did not decrease in any children except for two with unusually severe early onset disease. Conclusions. The progression of ADPKD clearly occurs in childhood and manifests as an increase in cyst number and renal size. This study identifies children at risk for rapid renal enlargement who may benefit the most from future therapeutic interventions.
引用
收藏
页码:1654 / 1662
页数:9
相关论文
共 50 条
  • [11] Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease
    Helal, Imed
    McFann, Kim
    Reed, Berenice
    Yan, Xiang-Dong
    Schrier, Robert W.
    Fick-Brosnahan, Godela M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (02) : 380 - 385
  • [12] Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
    Sans-Atxer, Laia
    Torra, Roser
    Fernandez-Llama, Patricia
    CLINICAL KIDNEY JOURNAL, 2013, 6 (05) : 457 - 463
  • [13] Treatment prospects for autosomal-dominant polycystic kidney disease
    Qian, Q
    Harris, PC
    Torres, VE
    KIDNEY INTERNATIONAL, 2001, 59 (06) : 2005 - 2022
  • [14] Gastrointestinal Manifestations of Autosomal-Dominant Polycystic Kidney Disease
    Mikolajczyk, Adam E.
    Te, Helen S.
    Chapman, Arlene B.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (01) : 17 - 24
  • [15] Recent advances in autosomal-dominant polycystic kidney disease
    Rangan, G. K.
    Tchan, M. C.
    Tong, A.
    Wong, A. T. Y.
    Nankivell, B. J.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (08) : 883 - 892
  • [16] Molecular basis of autosomal-dominant polycystic kidney disease
    A. R. Gallagher
    S. Hidaka
    N. Gretz
    R. Witzgall
    Cellular and Molecular Life Sciences CMLS, 2002, 59 : 682 - 693
  • [17] Glioma in Patients with Autosomal-Dominant Polycystic Kidney Disease
    Hao, Shuyu
    Feng, Jie
    Park, Deric M.
    Gao, Zhixian
    WORLD NEUROSURGERY, 2017, 98 : 885.e1 - 885.e5
  • [18] Molecular basis of autosomal-dominant polycystic kidney disease
    Gallagher, AR
    Hidaka, S
    Gretz, N
    Witzgall, R
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (04) : 682 - 693
  • [19] PROGNOSIS OF AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE
    SIMON, P
    NEPHRON, 1995, 71 (02): : 247 - 248
  • [20] Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease
    Tevfik Ecder
    Robert W. Schrier
    Nature Reviews Nephrology, 2009, 5 : 221 - 228